Wants to try to get above $2 so can fill the GAP of last Monday ($3.05).
It will climb the wall of worry until fills the gap and then based on that obtained energy will get to $4-5 soon after then wait for any news before aiming for $8-10. Expect $17-27 once the first revenues starts pouring back in. Omontys is at minimum a BILLION dollar per year drug (conservatively speaking) and now that Omontys is made such a widely spread news with all dialysis patients and centers and doctors and its name is become more widely known, specially costs and ONCE A MONTH issue about it (Amgen had worked hard to keep such facts from spreading and has signed multi-year monopoly contract to keep Omontys out) I believe, as does Seeking Alpha, that sales and revenues will be much better than ever. Remember there would be another huge free advertisement once it is brought back to the market. Of course there is also a good possibility that there would be a buy out before that (I suspect such a buy out, before Omontys is back in the market, would be for $8-12 per share..again being conservative).